Lakefront Biotherapeutics NV (G1LP34.SA) Q2 2025 Earnings

Apr 23Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-14.5
-9.09
-3.68
1.72

Details

Expected EPS
-0.838233360547275
Actual EPS
-14.50027896625
Surprise EPS
-13.66
Surprise Percent
-1,629.86%

Description

⁨Lakefront Biotherapeutics NV⁩ (⁦G1LP34.SA⁩) has reported earnings of ⁦-14.50027896625⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts